142 related articles for article (PubMed ID: 38406163)
1. Evaluating Tumor Necrosis Factor (TNF)-Alpha Pro-inflammatory Cytokines in Healthy and Oral Squamous Cell Carcinoma Patients With and Without Diabetes.
Azimudin R; Palati S; R P
Cureus; 2024 Jan; 16(1):e52890. PubMed ID: 38406163
[TBL] [Abstract][Full Text] [Related]
2. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
3. Association of serum and salivary tumor necrosis factor-α with histological grading in oral cancer and its role in differentiating premalignant and malignant oral disease.
Krishnan R; Thayalan DK; Padmanaban R; Ramadas R; Annasamy RK; Anandan N
Asian Pac J Cancer Prev; 2014; 15(17):7141-8. PubMed ID: 25227804
[TBL] [Abstract][Full Text] [Related]
4. Assessment of salivary levels of ErbB2 in oral squamous cell carcinoma.
Jayarajkumar S; Ramamoorthi R; Muniapillai S; Gopalakrishnan S; Jayaseelan VP
J Oral Maxillofac Pathol; 2023; 27(4):777. PubMed ID: 38304523
[TBL] [Abstract][Full Text] [Related]
5. Role of selected salivary inflammatory cytokines in the diagnosis and prognosis of oral squamous cell carcinoma. A Systematic Review and Meta-analysis.
Benito-Ramal E; Egido-Moreno S; González-Navarro B; Jané-Salas E; Roselló-Llabrés X; López-López J
Med Oral Patol Oral Cir Bucal; 2023 Sep; 28(5):e474-e486. PubMed ID: 37099710
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Babiuch K; Kuśnierz-Cabala B; Kęsek B; Okoń K; Darczuk D; Chomyszyn-Gajewska M
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32245251
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
8. Salivary and Serum Interleukin-6: A Credible Marker for Predicting Oral Leukoplakia and Oral Squamous Cell Carcinoma by Enzyme-Linked Immunosorbent Assay (ELISA).
Oshin M; Kulkarni PG; D SPR; Deepthi G; S KS; S JK
Cureus; 2024 Apr; 16(4):e59113. PubMed ID: 38803729
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of TNF-α and IL-6 in saliva among diabetic retinopathy patients in East Coast Malaysia.
Khairul-Anwar I; Wan-Nazatul-Shima S; Siti-Lailatul-Akmar Z; Siti-Azrin AH; Zunaina E
Trop Med Int Health; 2022 Mar; 27(3):310-316. PubMed ID: 35048479
[TBL] [Abstract][Full Text] [Related]
10. Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma.
Dikova V; Jantus-Lewintre E; Bagan J
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33924500
[TBL] [Abstract][Full Text] [Related]
11. [Levels of interlukin-6 and tumor necrosis factor-α in saliva of patients with type 2 diabetes mellitus and oral lichen planus].
Liu Y; Jin JQ; Yuan ZF; Liu XS; Cao J; Guo XH; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):596-9. PubMed ID: 21844975
[TBL] [Abstract][Full Text] [Related]
12. Salivary and serum IL-10, TNF-α, TGF-β, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infections.
Polz-Dacewicz M; Strycharz-Dudziak M; Dworzański J; Stec A; Kocot J
Infect Agent Cancer; 2016; 11():45. PubMed ID: 27547238
[TBL] [Abstract][Full Text] [Related]
13. Increased salivary AKR1B10 level: Association with progression and poor prognosis of oral squamous cell carcinoma.
Ko HH; Peng HH; Cheng SJ; Kuo MY
Head Neck; 2018 Dec; 40(12):2642-2647. PubMed ID: 30430672
[TBL] [Abstract][Full Text] [Related]
14. Tumour Necrosis Factor Alpha (TNF-α) and Oral Squamous Cell Carcinoma.
Brierly G; Celentano A; Breik O; Moslemivayeghan E; Patini R; McCullough M; Yap T
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980727
[TBL] [Abstract][Full Text] [Related]
15. Analysis of tumor marker CA 125 in saliva of normal and oral squamous cell carcinoma patients: a comparative study.
Balan JJ; Rao RS; Premalatha BR; Patil S
J Contemp Dent Pract; 2012 Sep; 13(5):671-5. PubMed ID: 23250173
[TBL] [Abstract][Full Text] [Related]
16. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation.
Rai AK; Panda M; Das AK; Rahman T; Das R; Das K; Sarma A; Kataki AC; Chattopadhyay I
Arch Microbiol; 2021 Jan; 203(1):137-152. PubMed ID: 32783067
[TBL] [Abstract][Full Text] [Related]
17. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
18. Histopathological differentiation of oral squamous cell carcinoma and salivary lactate dehydrogenase: A biochemical study.
D'Cruz AM; Pathiyil V
South Asian J Cancer; 2015; 4(2):58-60. PubMed ID: 25992341
[TBL] [Abstract][Full Text] [Related]
19. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.
Aziz S; Ahmed SS; Ali A; Khan FA; Zulfiqar G; Iqbal J; Khan AA; Shoaib M
Cancer Invest; 2015; 33(7):318-28. PubMed ID: 26046681
[TBL] [Abstract][Full Text] [Related]
20. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.
Csősz É; Lábiscsák P; Kalló G; Márkus B; Emri M; Szabó A; Tar I; Tőzsér J; Kiss C; Márton I
PLoS One; 2017; 12(5):e0177282. PubMed ID: 28545132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
